Miromatrix Medical Inc

NASDAQ:MIRO  
3.80
+0.08 (+2.15%)
Earnings Announcements

Miromatrix Reports Fourth Quarter And Full Year 2021 Results And Provides Corporate Update

Published: 03/30/2022 20:10 GMT
Miromatrix Medical Inc (MIRO) - Miromatrix Reports Fourth Quarter and Full Year 2021 Results and Provides Corporate Update.
Miromatrix Medical Inc - Believe Cash is Sufficient to Last Through 2023 and Enable Achievement of Key Milestones.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.33

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.49

More details on our Analysts Page.